BBC News
By Justin Rowlatt
image captionKaye Flitney is one of those enrolled on the clinical trial
A large-scale trial of a new treatment it is hoped will help stop Covid-19 patients from developing severe illness has begun in the UK.
The first patient received the treatment at Hull Royal Infirmary on Tuesday afternoon.
It involves inhaling a protein called interferon beta which the body produces when it gets a viral infection.
The hope is it will stimulate the immune system, priming cells to be ready to fight off viruses.
Early findings suggested the treatment cut the odds of a Covid-19 patient in hospital developing severe disease - such as requiring ventilation - by almost 80%.
A new potentially life-saving inhaler-based treatment which is hoped will protect COVID-19 patients from developing severe illness has begun a major trial at UK hospitals.
Wetland methane cycling increased during a rapid global warming event 56 million years ago and could foreshadow changes the methane cycle will experience in the future, according to new research led by the University of Bristol.
LONDON : A new potentially life-saving inhaler-based treatment which is hoped will protect COVID-19 patients from developing severe illness has begun a